PeriOperative Bridging - Perioperative Anticoagulation in the Setting of Recent Intracoronary Drug Eluting Stents
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00606151 |
Recruitment Status :
Terminated
(subject enrollment goals not met)
First Posted : February 1, 2008
Last Update Posted : March 26, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Stent Thrombosis |
Study Type : | Observational |
Estimated Enrollment : | 60 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Short-Term Outcomes of Perioperative Anticoagulation in the Setting of Recent Intracoronary Drug Eluting Stents |
Study Start Date : | January 2008 |
Actual Primary Completion Date : | January 2009 |
Actual Study Completion Date : | January 2009 |
- stent thrombosis [ Time Frame: hospitalization ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Aged 18 years or greater, able to give consent
- DES implantation < or = 6 months prior to admission
- Undergoing an invasive surgical procedure that will require cessation of clopidogrel therapy for >48 hours
Exclusion Criteria:
- Age < 18 years
- Refusal to give consent
- Surgical procedure performed without discontinuation of clopidogrel therapy (or < 48h of clopidogrel cessation)
- Ongoing anticoagulant therapy other than aspirin (i.e. warfarin, ticlopidine)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00606151
United States, Ohio | |
Cleveland Clinic | |
Cleveland, Ohio, United States, 44195 |
Principal Investigator: | Matthew (Casey) Becker, MD | The Cleveland Clinic |
Responsible Party: | Matthew Becker, MD, Cleveland Clinic |
ClinicalTrials.gov Identifier: | NCT00606151 |
Other Study ID Numbers: |
07669 07669 |
First Posted: | February 1, 2008 Key Record Dates |
Last Update Posted: | March 26, 2009 |
Last Verified: | March 2009 |
drug eluding stents perioperative bridging Stents |
Thrombosis Embolism and Thrombosis Vascular Diseases Cardiovascular Diseases |